Heather Raymon
23Patents
8h-index
44Co-inventors
75Inventor score
Filing activity: Apr 14, 1998 → Feb 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9512124B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 24 | Active |
| US8680076B2 | Methods of treatment, improvement and prevention using haloaryl substituted aminopurines | Human Necessities | 15 | Active |
| US6835567B1 | PNS cell lines and methods of use therefor | Chemistry; Metallurgy | 12 | Expired |
| US9505764B2 | Treatment of cancer with dihydropyrazino-pyrazines | Chemistry; Metallurgy | 11 | Active |
| US6987184B2 | Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related | Chemistry; Metallurgy | 10 | Expired |
| US9737541B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 9 | Active |
| US7354947B2 | Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto | Chemistry; Metallurgy | 8 | Expired |
| US6913925B1 | Human mesencephalon cell lines and methods of use therefor | Chemistry; Metallurgy | 8 | Expired |
| US9493466B2 | Treatment of cancer with TOR kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9630966B2 | Treatment of cancer with dihydropyrazino-pyrazines | Chemistry; Metallurgy | 4 | Active |
| US9782427B2 | Methods for treating cancer using TOR kinase inhibitor combination therapy | Chemistry; Metallurgy | 3 | Active |
| US10940152B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US9937170B2 | Treatment of cancer with TOR kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10646493B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US12084499B2 | SIRP-α binding proteins and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10391092B2 | Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy | Human Necessities | 0 | Active |
| US10183019B2 | Treatment of cancer with dihydropyrazino-pyrazines | Chemistry; Metallurgy | 0 | Active |
| US10576085B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Human Necessities | 0 | Active |
| US11590139B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US11591390B2 | SIRP-α binding proteins and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US9937169B2 | Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy | Human Necessities | 0 | Active |
| US11166950B2 | Treatment of cancer with TOR kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9980963B2 | Treatment of cancer with dihydropyrazino-pyrazines | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.